Higher expression of FOXOs correlates to better prognosis of bladder cancer.

about

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

Item

http://www.wikidata.org/entity/Q47134698

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@en

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@nl

type

Item

label

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@en

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@nl

prefLabel

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@en

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@nl

P1476

Higher expression of FOXOs correlates to better prognosis of bladder cancer.

@en

P2093

Hai Li

http://www.w3.org/2001/XMLSchema#string

Linpei Jia

http://www.w3.org/2001/XMLSchema#string

Wei Ji

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4

The FoxO code

FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.

Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade

Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancer

A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.

FoxOs in tumor suppression and stem cell maintenance.

Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer.

The management of BCG failure in non-muscle-invasive bladder cancer: an update.

P304

96313-96322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22029

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29221208

http://www.w3.org/2001/XMLSchema#string

P932

5707102

http://www.w3.org/2001/XMLSchema#string